XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 6,491 $ 2,925
General and administrative 15,849 1,286
Total operating expenses 22,340 4,211
Loss from operations (22,340) (4,211)
Other income (expense), net (116)  
Change in fair value of financial instruments 3,168 581
Total other income (expense), net 3,052 581
Net loss and comprehensive loss $ (19,288) $ (3,630) [1]
Net loss per share—basic $ (23.43) $ (46.13)
Net loss per share—diluted $ (23.43) $ (46.13)
Weighted-average number of shares outstanding used in computing net loss per share—basic 823,069 78,678
Weighted-average number of shares outstanding used in computing net loss per share—diluted 823,069 78,678
[1]

(1) Retroactively restated for the reverse recapitalization as described in Note 2.